HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susan G Kornstein Selected Research

Desvenlafaxine Succinate

5/2016An integrated analysis of the efficacy and safety of desvenlafaxine in the treatment of major depressive disorder.
11/2015Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder: a meta-analysis.
4/2015A pooled analysis of the efficacy of desvenlafaxine for the treatment of major depressive disorder in perimenopausal and postmenopausal women.
9/2014The effect of desvenlafaxine 50 mg/day on a subpopulation of anxious/depressed patients: a pooled analysis of seven randomized, placebo-controlled studies.
8/2014Post hoc analysis of the efficacy and safety of desvenlafaxine 50 mg/day in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.
7/2014Desvenlafaxine for the treatment of major depressive disorder.
10/2013Efficacy and safety of desvenlafaxine 50 mg/d in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.
3/2011Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.
8/2010Short-term efficacy and safety of desvenlafaxine in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.
7/2010Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susan G Kornstein Research Topics

Disease

43Major Depressive Disorder (Major Depressive Disorders)
05/2016 - 01/2002
5Anxiety Disorders (Anxiety Disorder)
02/2009 - 05/2002
4Dysthymic Disorder
06/2007 - 03/2002
3Premenstrual Syndrome (Premenstrual Tension)
04/2017 - 10/2006
3Premenstrual Dysphoric Disorder
10/2015 - 10/2006
3Pain (Aches)
10/2013 - 05/2006
3Fatigue
10/2009 - 10/2008
3Sleep Initiation and Maintenance Disorders (Insomnia)
01/2009 - 06/2002
3Depressive Disorder (Melancholia)
08/2007 - 06/2002
2Substance-Related Disorders (Drug Abuse)
01/2018 - 05/2009
2Medically Unexplained Symptoms
01/2009 - 07/2007
1Dizziness (Lightheadedness)
01/2022
1Nausea
01/2022
1Vertigo (Positional Vertigo)
01/2022
1Treatment-Resistant Depressive Disorder
01/2022
1Binge-Eating Disorder (Binge Eating Disorder)
01/2019
1Intellectual Disability (Idiocy)
10/2018
1Cardiovascular Diseases (Cardiovascular Disease)
01/2018
1Polycystic Kidney Diseases (Polycystic Kidney Disease)
01/2018
1Body Weight (Weight, Body)
11/2017
1Weight Loss (Weight Reduction)
11/2017
1Psychological Sexual Dysfunctions (Sexual Arousal Disorder)
11/2017
1Bulimia (Binge Eating)
01/2016
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
10/2015
1Erectile Dysfunction
04/2009
1Paralysis (Palsy)
10/2008
1Headache (Headaches)
01/2008
1Disorders of Excessive Somnolence (Hypersomnia)
08/2007
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
08/2007
1Weight Gain
08/2007
1Personality Disorders (Personality Disorder)
05/2003
1Acute-Phase Reaction
01/2003

Drug/Important Bio-Agent (IBA)

15Desvenlafaxine SuccinateFDA Link
05/2016 - 01/2009
11Antidepressive Agents (Antidepressants)IBA
03/2013 - 06/2002
10Duloxetine Hydrochloride (Cymbalta)FDA Link
01/2012 - 05/2006
9Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
01/2014 - 09/2005
8Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
10/2015 - 09/2005
6Sertraline (Zoloft)FDA LinkGeneric
10/2015 - 03/2002
6nefazodone (Serzone)FDA LinkGeneric
10/2003 - 01/2002
5Fluoxetine (Prozac)FDA LinkGeneric
01/2014 - 11/2006
5EscitalopramFDA Link
10/2011 - 11/2006
4CitalopramFDA LinkGeneric
09/2010 - 11/2006
3Norepinephrine (Noradrenaline)FDA LinkGeneric
07/2010 - 04/2009
3Serotonin (5 Hydroxytryptamine)IBA
07/2010 - 04/2009
3Imipramine (Janimine)FDA LinkGeneric
06/2007 - 03/2002
2Hormones (Hormone)IBA
07/2010 - 08/2007
1EsketamineIBA
01/2022
1Nasal SpraysIBA
01/2022
1Lisdexamfetamine DimesylateFDA Link
01/2019
1Biological ProductsIBA
10/2018
1VaccinesIBA
01/2018
1Serotonin 5-HT2 Receptor AntagonistsIBA
11/2017
1Serotonin 5-HT1 Receptor AgonistsIBA
11/2017
1flibanserin (BIMT 17)IBA
11/2017
1pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate (PMTS)IBA
10/2015
1Serotonin and Noradrenaline Reuptake InhibitorsIBA
06/2009
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
01/2008
1Progestins (Progestagens)IBA
08/2007
1Contraceptive Agents (Contraceptives)IBA
08/2007
1Bupropion (Wellbutrin)FDA LinkGeneric
07/2007
1Pharmaceutical PreparationsIBA
06/2007
1Paroxetine (Paxil)FDA LinkGeneric
11/2006
15-HT2 Serotonin ReceptorsIBA
06/2002

Therapy/Procedure

10Therapeutics
03/2011 - 06/2002
5Drug Therapy (Chemotherapy)
01/2016 - 06/2002
1Hormonal Contraception
04/2017